This inventor holds 7 USPTO granted patents. Top assignees: The Rockefeller University, The Picower Institute for Medical Research, Other. Active years: 1992-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1992-2000
Title: The Innovative Contributions of Barbara A. Sherry
Introduction
Barbara A. Sherry is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biomedical research, particularly in the area of inflammatory cytokines and myelopoietic blood cell production. With a total of 7 patents to her name, her work has paved the way for advancements in diagnostic and therapeutic applications.
Latest Patents
One of her latest patents involves a composition comprising an antibody to macrophage-derived inflammatory cytokines. This invention discloses an inflammatory cytokine isolated from cells incubated with a stimulator material. The cytokine is characterized by its ability to bind to heparin and induce localized inflammation, which is marked by polymorphonuclear cell infiltration when administered subcutaneously. It exhibits potent in vitro chemotactic activity while inducing minimal chemokinesis in polymorphonuclear cells. Additionally, it does not suppress the activity of the anabolic enzyme lipoprotein lipase or stimulate the production of cachectin/TNF by primary thioglycollate-elicited mouse macrophage cells. The cDNA of this particular inflammatory cytokine has been sequenced, predicting a length of 74 amino acids and a molecular weight of 7,908. The patent also proposes various diagnostic and therapeutic utilities, along with testing procedures and pharmaceutical compositions.
Another notable patent by Sherry relates to methods of treating granulocyte-macrophage progenitor cell-derived blood. This invention identifies promoters of myelopoietic blood cell production and discovers an agent that enhances myelopoietic colony-stimulating factor activity. The agent comprises cytokines capable of binding to heparin and inducing localized inflammation. The inflammatory cytokines MIP-1 and MIP-2 are highlighted as particular agents in this patent, which also proposes diagnostic and therapeutic utilities.
Career Highlights
Barbara A. Sherry has worked at prestigious institutions such as The Rockefeller University and the Picower Institute for Medical Research. Her research has significantly impacted the understanding of inflammatory processes and blood cell production.
Collaborations
Throughout her career, Sherry has collaborated with notable scientists, including Anthony Cerami and Stephen D. Wolpe. These collaborations have further enriched her research and contributed to her innovative discoveries.
Conclusion
Barbara A. Sherry's contributions
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile